Other treatments for dyspnea

Dyspnea: Mechanisms, Measurement, and Management, Third Edition

Volumn , Issue , 2014, Pages 207-221

  Mahler, Donald A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84920725518     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (121)

1. Spahija J, Marchie Md, Ghezzo H, Grassino A. Factors discriminating spontaneous pursed-lips breathing use in patients with COPD. COPD 2010;7(4):254-61.
2. Mueller RE, Petty TL, Filley GF. Ventilation and arterial blood gas changes induced by pursed lips breathing. J Appl Physiol 1970;28(6):784-9.
3. Tiep BL, Burns M, Kao D, Madison R, Herrera J. Pursed lips breathing training using ear oximetry. Chest 1986;90(2):218-21.
4. Breslin EH. The pattern of respiratory muscle recruitment during pursed-lip breathing. Chest 1992;101(1):75-8.
5. Lanini B, Masolini M, Bianchi R, Binazzi B, Romagnoli I, Gigliotti F, et al. Chest wall kinematics during voluntary cough in neuromuscular patients. Respir Physiol Neurobiol 2008;161(1):62-8.
6. Gosselink R. Breathing techniques in patients with chronic obstructive pulmonary disease (COPD). Chron Respir Dis 2004;1(3):163-72.
7. Sharp JT, Drutz WS, Moisan T, Foster J, Machnach W. Postural relief of dyspnea in severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1980;122(2):201-11.
8. O'Neill S, McCarthy DS. Postural relief of dyspnoea in severe chronic airflow limitation: Relationship to respiratory muscle strength. Thorax 1983;38(8):595-600.
9. Schwartzstein RM, Lahive K, Pope A, Weinberger SE, Weiss JW. Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis 1987;136(1):58-61.
10. Galbraith S, Fagan P, Perkins P, Lynch A, Booth S. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage 2010;39(5):831-8.
11. Bauldoff GS, Hoffman LA, Zullo TG, Sciurba FC. Exercise maintenance following pulmonary rehabilitation: Effect of distractive stimuli. Chest 2002;122(3):948-54.
12. Brooks D, Sidani S, Graydon J, McBride S, Hall L, Weinacht K. Evaluating the effects of music on dyspnea during exercise in individuals with chronic obstructive pulmonary disease: A pilot study. Rehabil Nurs 2003;28(6):192-6.
13. Singh VP, Rao V, Prem V, Sahoo RC, Keshav Pai K. Comparison of the effectiveness of music and progressive muscle relaxation for anxiety in COPD-A randomized controlled pilot study. ChronRespirDis 2009;6(4):209-16.
14. Gifford AH, Mahler DA, Waterman LA, Ward J, Kraemer WJ, Kupchak BR, et al. Neuromodulatory effect of endogenous opioids on the intensity and unpleasantness of breathlessness during resistive load breathing in COPD. COPD 2011;8(3):160-6.
15. Bellofiore S, Di Maria GU, Privitera S, Sapienza S, Milic-Emili J, Mistretta A. Endogenous opioids modulate the increase in ventilatory output and dyspnea during severe acute bronchoconstriction. Am Rev Respir Dis 1990;142(4):812-6.
16. Mahler DA, Murray JA, Waterman LA, Ward J, Kraemer WJ, Zhang X, et al. Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD. Eur Respir J 2009;33(4):771-7.
17. Mahler DA, Gifford AH, Waterman LA, Ward J, Kraemer WJ, Kupchak BR, et al. Effect of increased blood levels of beta-endorphin on perception of breathlessness. Chest 2013;143(5):1378-85.
18. Gambert SR, Garthwaite TL, Pontzer CH, Cook EE, Tristani FE, Duthie EH, et al. Running elevates plasma beta-endorphin immunoreactivity and ACTH in untrained human subjects. Proc Soc Exp Biol Med 1981;168(1):1-4.
19. Kraemer WJ, Patton JF, Knuttgen HG, Marchitelli LJ, Cruthirds C, Damokosh A, et al. Hypothalamic-pituitaryadrenal responses to short-duration high-intensity cycle exercise. JAppl Physiol 1989;66(1):161-6.
20. Boecker H, Sprenger T, Spilker ME, Henriksen G, Koppenhoefer M, Wagner KJ, et al. The runner's high: Opioidergic mechanisms in the human brain. Cereb Cortex 2008;18(11):2523-31.
21. Drewnowski A, Krahn DD, Demitrack MA, Nairn K, Gosnell BA. Taste responses and preferences for sweet high-fat foods: Evidence for opioid involvement. Physiol Behav 1992;51(2):371-9.
22. Melchior JC, Rigaud D, Colas-Linhart N, Petiet A, Girard A, Apfelbaum M. Immunoreactive beta-endorphin increases after an aspartame chocolate drink in healthy human subjects. Physiol Behav 1991;50(5):941-4.
23. Laurent D, Schneider KE, Prusaczyk WK, Franklin C, Vogel SM, Krssak M, et al. Effects of caffeine on muscle glycogen utilization and the neuroendocrine axis during exercise. J Clin Endocrinol Metab 2000;85(6):2170-5.
24. Arnold MA, Carr DB, Togasaki DM, Pian MC, Martin JB. Caffeine stimulates beta-endorphin release in blood but not in cerebrospinal fluid. Life Sci 1982;31(10):1017-24.
25. Levins PC, Carr DB, Fisher JE, Momtaz K, Parrish JA. Plasma beta-endorphin and beta-lipoprotein response to ultraviolet radiation. Lancet 1983;2(8342):166.
26. Mier-Jedrzejowicz A, Brophy C, Green M. Respiratory muscle weakness during upper respiratory tract infections. Am Rev Respir Dis 1988;138(1):5-7.
27. Laroche CM, Cairns T, Moxham J, Green M. Hypothyroidism presenting with respiratory muscle weakness. Am Rev Respir Dis 1988;138(2):472-4.
28. Mulvey DA, Aquilina RJ, Elliott MW, Moxham J, Green M. Diaphragmatic dysfunction in neuralgic amyotrophy: An electrophysiologic evaluation of 16 patients presenting with dyspnea. Am Rev Respir Dis 1993;147(1):66-71.
29. Lisboa C, Borzone G. Inspiratory muscle training. In Mahler DA, O'Donnell DE, editors. Dyspnea: Mechanisms, Measurement, and Management. 2nd edition. Boca Raton, FL: Taylor and Francis; 2005. pp. 321-54.
30. McParland C, Krishnan B, Wang Y, Gallagher CG. Inspiratory muscle weakness and dyspnea in chronic heart failure. Am Rev Respir Dis 1992;146(2):467-72.
31. Begin P, Grassino A. Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease. Am Rev Respir Dis 1991;143(5 Pt 1): 905-12.
32. Polkey MI, Kyroussis D, Hamnegard CH, Mills GH, Green M, Moxham J. Diaphragm strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154(5):1310-7.
33. Ottenheijm CA, Heunks LM, Sieck GC, Zhan WZ, Jansen SM, Degens H, et al. Diaphragm dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172(2):200-5.
34. McParland C, Resch EF, Krishnan B, Wang Y, Cujec B, Gallagher CG. Inspiratory muscle weakness in chronic heart failure: Role of nutrition and electrolyte status and systemic myopathy. Am J Respir Crit Care Med 1995;151(4):1101-7.
35. Leith DE, Bradley M. Ventilatory muscle strength and endurance training. JAppl Physiol 1976;41(4):508-16.
36. Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, et al. Pulmonary rehabilitation: Joint ACCP/ AACVPR evidence-based clinical practice guidelines. Chest 2007;131(5 Suppl):4S-42S.
37. Gosselink R, De Vos J, van den Heuvel SP, Segers J, Decramer M, Kwakkel G. Impact of inspiratory muscle training in patients with COPD: What is the evidence? Eur Respir J 2011;37(2):416-25.
38. Lin SJ, McElfresh J, Hall B, Bloom R, Farrell K. Inspiratory muscle training in patients with heart failure: A systematic review. Cardiopulm Phys Ther J 2012;23(3):29-36.
39. Cahalin LP, Arena R, Guazzi M, Myers J, Cipriano G, Chiappa G, et al. Inspiratory muscle training in heart disease and heart failure: A review of the literature with a focus on method of training and outcomes. Expert Rev Cardiovasc Ther 2013;11(2):161-77.
40. Hunt T, Williams MT, Frith P, Schembri D. Heliox, dyspnoea and exercise in COPD. Eur Respir Rev. 2010;19(115):30-8.
41. Oga T, Nishimura K, Tsukino M, Hajiro T, Ikeda A, Izumi T. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests. Am J Respir Crit Care Med 2000;161(6):1897-901.
42. Mahler DA. Measurement of dyspnea ratings during exercise. In Mahler DA, O'Donnell DE, editors. Dyspnea: Mechanisms, Measurement, and Management. 2nd edition. Boca Raton, FL: Taylor and Francis; 2005, pp. 167-82.
43. O'Donnell DE, Ora J, Webb KA, Laveneziana P, Jensen D. Mechanisms of activity-related dyspnea in pulmonary diseases. Respir Physiol Neurobiol 2009;167(1):116-32.
44. Eves ND, Petersen SR, Haykowsky MJ, Wong EY, Jones RL. Helium-hyperoxia, exercise, and respiratory mechanics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174(7):763-71.
45. Palange P, Valli G, Onorati P, Antonucci R, Paoletti P, Rosato A, et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol 2004;97(5):1637-42.
46. Laude EA, Duffy NC, Baveystock C, Dougill B, Campbell MJ, Lawson R, et al. The effect of helium and oxygen on exercise performance in chronic obstructive pulmonary disease: A randomized crossover trial. Am JRespir Crit Care Med 2006;173(8):865-70.
47. Chiappa GR, Queiroga F Jr, Meda E, Ferreira LF, Diefenthaeler F, Nunes M, et al. Heliox improves oxygen delivery and utilization during dynamic exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;179(11):1004-10.
48. D'Angelo E, Santus P, Civitillo MF, Centanni S, Pecchiari M. Expiratory flow-limitation and heliox breathing in resting and exercising COPD patients. Respir Physiol Neurobiol 2009;169(3):291-6.
49. Marciniuk DD, Butcher SJ, Reid JK, MacDonald GF, Eves ND, Clemens R, et al. The effects of helium-hyperoxia on 6-min walking distance in COPD: A randomized, controlled trial. Chest 2007;131(6):1659-65.
50. Oelberg DA, Kacmarek RM, Pappagianopoulos PP, Ginns LC, Systrom DM. Ventilatory and cardiovascular responses to inspired He-O2 during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158(6):1876-82.
51. Richardson RS, Sheldon J, Poole DC, Hopkins SR, Ries AL, Wagner PD. Evidence of skeletal muscle metabolic reserve during whole body exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159(3):881-5.
52. Babb TG. Breathing He-O2 increases ventilation but does not decrease the work of breathing during exercise. Am J Respir Crit Care Med 2001;163(5):1128-34.
53. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14(5):377-81.
54. Moga AM, de Marchie M, Saey D, Spahija J. Mechanisms of non-pharmacologic adjunct therapies used during exercise in COPD. Respir Med 2012;106(5):614-26.
55. O'Donnell DE, Sanii R, Younes M. Improvement in exercise endurance in patients with chronic airflow limitation using continuous positive airway pressure. Am Rev Respir Dis 1988;138(6):1510-4.
56. Borghi-Silva A, Oliveira CC, Carrascosa C, Maia J, Berton DC, Queiroga F Jr, et al. Respiratory muscle unloading improves leg muscle oxygenation during exercise in patients with COPD. Thorax 2008;63(10):910-5.
57. Kyroussis D, Polkey MI, Hamnegard CH, Mills GH, Green M, Moxham J. Respiratory muscle activity in patients with COPD walking to exhaustion with and without pressure support. Eur Respir J 2000;15(4):649-55.
58. Hernandez P, Maltais F, Gursahaney A, Leblanc P, Gottfried SB. Proportional assist ventilation may improve exercise performance in severe chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2001;21(3):135-42.
59. Maltais F, Reissmann H, Gottfried SB. Pressure support reduces inspiratory effort and dyspnea during exercise in chronic airflow obstruction. Am J Respir Crit Care Med 1995;151(4):1027-33.
60. Petrof BJ, Calderini E, Gottfried SB. Effect of CPAP on respiratory effort and dyspnea during exercise in severe COPD. J Appl Physiol 1990;69(1):179-88.
61. Wijkstra PJ, Wempe JB. New tools in pulmonary rehabilitation. EurRespir J 2011;38(6):1468-74.
62. Sillen MJ, Speksnijder CM, Eterman RM, Janssen PP, Wagers SS, Wouters EF, et al. Effects of neuromuscular electrical stimulation of muscles of ambulation in patients with chronic heart failure or COPD: A systematic review of the English-language literature. Chest 2009;136(1):44-61.
63. Roig M, Reid WD. Electrical stimulation and peripheral muscle function in COPD: A systematic review. Respir Med 2009;103(4):485-95.
64. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, et al. American Thoracic Society/ European Respiratory Society statement on pulmonary rehabilitation. Am JRespir Crit Care Med 2006;173(12): 1390-413.
65. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-46.
66. Connolly JE. Results of bullectomy. Chest Surg Clin N Am 1995;5(4):765-76.
67. Palla A, Desideri M, Rossi G, Bardi G, Mazzantini D, Mussi A, et al. Elective surgery for giant bullous emphysema: A 5-year clinical and functional follow-up. Chest 2005;128(4):2043-50.
68. O'Donnell DE, Webb KA, Bertley JC, Chau LK, Conlan AA. Mechanisms of relief of exertional breathlessness following unilateral bullectomy and lung volume reduction surgery in emphysema. Chest 1996;110(1):18-27.
69. Schipper PH, Meyers BF, Battafarano RJ, Guthrie TJ, Patterson GA, Cooper JD. Outcomes after resection of giant emphysematous bullae. Ann Thorac Surg 2004;78(3):976-82; discussion 976-82.
70. Cooper JD, Patterson GA, Sundaresan RS, Trulock EP, Yusen RD, Pohl MS, et al. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 1996;112(5):1319-29; discussion 1329-30.
71. Martinez FJ, de Oca MM, Whyte RI, Stetz J, Gay SE, Celli BR. Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med 1997;155(6):1984-90.
72. Patel SA, Sciurba FC. Management of dyspnea: Lung volume reduction surgery. In Mahler DA, O'Donnell DE, editors. Dyspnea: Mechanisms, Measurement and Management. 2nd edition. Boca Raton, FL: Taylor and Francis; 2005, pp. 397-418.
73. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348(21):2059-73.
74. Ries AL. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and visual analog scale. COPD 2005;2(1): 105-10.
75. Naunheim KS, Wood DE, Mohsenifar Z, Sternberg AL, Criner GJ, DeCamp MM, et al. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006;82(2):431-43.
76. Berger RL, Decamp MM, Criner GJ, Celli BR. Lung volume reduction therapies for advanced emphysema: An update. Chest 2010;138(2):407-17.
77. Silvestri GA, Feller-Kopman D, Chen A, Wahidi M, Yasufuku K, Ernst A. Latest advances in advanced diagnostic and therapeutic pulmonary procedures. Chest 2012;142(6):1636-44.
78. Eberhardt R, Gompelmann D, Schuhmann M, Reinhardt H, Ernst A, Heussel CP, et al. Complete unilateral versus partial bilateral endoscopic lung volume reduction in patients with bilateral lung emphysema. Chest 2012;142(4):900-8.
79. Herth FJ, Noppen M, Valipour A, Leroy S, Vergnon JM, Ficker JH, et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J 2012;39(6):1334-42.
80. Hopkinson NS, Kemp SV, Toma TP, Hansell DM, Geddes DM, Shah PL, et al. Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J 2011;37(6):1346-51.
81. Criner GJ, Pinto-Plata V, Strange C, Dransfield M, Gotfried M, Leeds W, et al. Biologic lung volume reduction in advanced upper lobe emphysema: Phase 2 results. Am J Respir Crit Care Med 2009;179(9):791-8.
82. Choong CK, Phan L, Massetti P, Haddad FJ, Martinez C, Roschak E, et al. Prolongation of patency of airway bypass stents with use of drug-eluting stents. J Thorac Cardiovasc Surg 2006;131(1):60-4.
83. Grgic A, Wilkens H, Kubale R, Groschel A, Buecker A, Sybrecht GW. Low-dose MDCT for surveillance of patients with severe homogeneous emphysema after bronchoscopic airway bypass. AJR Am J Roentgenol 2008;191(3):W112-9.
84. Shah PL, Slebos DJ, Cardoso PF, Cetti EJ, Sybrecht GW, Cooper JD. Design of the Exhale Airway Stents for Emphysema (EASE) trial: An endoscopic procedure for reducing hyperinflation. BMC Pulm Med 2011;11:1.
85. Snell G, Herth FJ, Hopkins P, Baker KM, Witt C, Gotfried MH, et al. Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. Eur Respir J 2012;39(6):1326-33.
86. Ninane V, Geltner C, Bezzi M, Foccoli P, Gottlieb J, Welte T, et al. Multicentre European study for the treatment of advanced emphysema with bronchial valves. Eur Respir J 2012;39(6):1319-25.
87. Sciurba FC, Ernst A, Herth FJ, Strange C, Criner GJ, Marquette CH, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010;363(13):1233-44.
88. Tanigawa N, Sawada S, Okuda Y, Kobayashi M, Mishima K. Symptomatic improvement in dyspnea following tracheobronchial metallic stenting for malignant airway obstruction. Acta Radiol 2000;41(5):425-8.
89. Miyazawa T, Miyazu Y, Iwamoto Y, Ishida A, Kanoh K, Sumiyoshi H, et al. Stenting at the flow-limiting segment in tracheobronchial stenosis due to lung cancer. Am J Respir Crit Care Med 2004;169(10):1096-102.
90. Lau KS, Jones AY. A single session of acu-TENS increases FEV1 and reduces dyspnoea in patients with chronic obstructive pulmonary disease: A randomized, placebo-controlled trial. Aust J Physiother 2008;54(3):179-84.
91. Ahsin S, Saleem S, Bhatti AM, Iles RK, Aslam M. Clinical and endocrinological changes after electro-acupuncture treatment in patients with osteoarthritis of the knee. Pain 2009;147(1-3):60-6.
92. Ngai SP, Jones AY, Hui-Chan CW, Ko FW, Hui DS. An adjunct intervention for management of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). J Altern Complement Med 2013;19(2):178-81.
93. Sjolund B, Terenius L, Eriksson M. Increased cerebrospinal fluid levels of endorphins after electro-acupuncture. Acta Physiol Scand 1977;100(3):382-4.
94. Clement-Jones V, McLoughlin L, Tomlin S, Besser GM, Rees LH, Wen HL. Increased beta-endorphin but not met-enkephalin levels in human cerebrospinal fluid after acupuncture for recurrent pain. Lancet 1980;2(8201):946-9.
95. Joos S, Schott C, Zou H, Daniel V, Martin E. Immunomodulatory effects of acupuncture in the treatment of allergic asthma: A randomized controlled study. J Altern Complement Med 2000;6(6):519-25.
96. Christensen PA, Laursen LC, Taudorf E, Sorensen SC, Weeke B. Acupuncture and bronchial asthma. Allergy 1984;39(5):379-85.
97. Chae Y, Chang DS, Lee SH, Jung WM, Lee IS, Jackson S, et al. Inserting needles into the body: A meta-analysis of brain activity associated with acupuncture needle stimulation. J Pain 2013;14(3):215-22.
98. Ngai SP, Hui-Chan CW, Jones AY. A short review of acupuncture and bronchial asthma-Western and traditional Chinese medical concepts. Hong Kong Physiother J 2006;24:28-38.
99. Maa SH, Sun MF, Hsu KH, Hung TJ, Chen HC, Yu CT, et al. Effect of acupuncture or acupressure on quality of life of patients with chronic obstructive asthma: A pilot study. J Altern Complement Med 2003;9(5):659-70.
100. Suzuki M, Namura K, Ohno Y, Tanaka H, Egawa M, Yokoyama Y, et al. The effect of acupuncture in the treatment of chronic obstructive pulmonary disease. J Altern Complement Med 2008;14(9):1097-105.
101. Jones AY, Ngai SP, Hui-Chan CW, Yu HP. Acute effects of acu-TENS on FEV1 and blood beta-endorphin level in chronic obstructive pulmonary disease. Altern Ther Health Med 2011;17(5):8-13.
102. Ngai SP, Jones AY, Hui-Chan CW, Ko FW, Hui DS. Effect of 4 weeks of acu-TENS on functional capacity and betaendorphin level in subjects with chronic obstructive pulmonary disease: A randomized controlled trial. Respir Physiol Neurobiol 2010;173(1):29-36.
103. Choi JY, Jung HJ, Kim JI, Lee MS, Kang KW, Roh YL, et al. A randomized pilot study of acupuncture as an adjunct therapy in adult asthmatic patients. J Asthma 2010;47(7):774-80.
104. Vickers AJ, Feinstein MB, Deng GE, Cassileth BR. Acupuncture for dyspnea in advanced cancer: A randomized, placebo-controlled pilot trial [ISRCTN89462491]. BMC Palliat Care 2005;4:5.
105. Jobst K, Chen JH, McPherson K, Arrowsmith J, Brown V, Efthimiou J, et al. Controlled trial of acupuncture for disabling breathlessness. Lancet 1986;2(8521-22):1416-9.
106. Lewith GT, Prescott P, Davis CL. Can a standardized acupuncture technique palliate disabling breathlessness: A single-blind, placebo-controlled crossover study. Chest 2004;125(5):1783-90.
107. Suzuki M, Muro S, Ando Y, Omori T, Shiota T, Endo K, et al. A randomized, placebo-controlled trial of acupuncture in patients with chronic obstructive pulmonary disease (COPD): The COPD-Acupuncture Trial (CAT). Arch Intern Med 2012;172(11):878-86.
108. Bausewein C, Booth S, Gysels M, Higginson I. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev 2008;(2):CD005623.
109. Yates P, Zhao I. Update on complex nonpharmacologi-cal interventions for breathlessness. Curr Opin Support Palliat Care 2012;6(2):144-52.
110. Sudo T, Hayashi F, Nishino T. Responses of tracheobronchial receptors to inhaled furosemide in anesthetized rats. Am JRespir Crit Care Med 2000;162(3 Pt 1):971-5.
111. Sant'Ambrogio FB, Sant'Ambrogio G, Anderson JW. Effect of furosemide on the response of laryngeal receptors to low-chloride solutions. Eur Respir J 1993;6(8):1151-5.
112. Jensen D, Amjadi K, Harris-McAllister V, Webb KA, O'Donnell DE. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD. Thorax 2008;63(7):606-13.
113. Moosavi SH, Binks AP, Lansing RW, Topulos GP, Banzett RB, Schwartzstein RM. Effect of inhaled furosemide on air hunger induced in healthy humans. Respir Physiol Neurobiol 2007;156(1):1-8.
114. Nishino T, Ide T, Sudo T, Sato J. Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea. Am J Respir Crit Care Med 2000;161(6):1963-7.
115. Stuart-Harris C, Bishop JM, Clark TJH, Dornhorst AC, Cotes JE, Flenley DC, et al. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981;1(8222):681-6.
116. Ong KC, Kor AC, Chong WF, Earnest A, Wang YT. Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;169(9):1028-33.
117. Nakayama H, Shibuya M, Yamada M, Suzuki H, Arakawa M, Homma I. In-phase chest wall vibration decreases dyspnea during arm elevation in chronic obstructive pulmonary disease patients. Intern Med 1998;37(10):831-5.
118. Cristiano LM, Schwartzstein RM. Effect of chest wall vibration on dyspnea during hypercapnia and exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;155(5):1552-9.
119. Sibuya M, Yamada M, Kanamaru A, Tanaka K, Suzuki H, Noguchi E, et al. Effect of chest wall vibration on dyspnea in patients with chronic respiratory disease. Am J Respir Crit Care Med 1994;149(5):1235-40.
120. Fujie T, Tojo N, Inase N, Nara N, Homma I, Yoshizawa Y. Effect of chest wall vibration on dyspnea during exercise in chronic obstructive pulmonary disease. Respir Physiol Neurobiol 2002;130(3):305-16.
121. Juan G, Ramon M, Valia JC, Cortijo J, Rubio E, Morcillo E, et al. Palliative treatment of dyspnea with epidural methadone in advanced emphysema. Chest 2005;128(5):3322-8.